The Latest Breaking News from ZTS

Is Zoetis a Smart Investment in the Pharmaceuticals Sector?

Zoetis (ZTS) reported strong financial results for the last reported quarter. Amid the growing attention and concern on animal health and care, ZTS’ diverse product portfolio stands to benefit significantly from its continuous product innovations. So, should you buy this innovative pharmaceutical stock considering the current trends? Read more to…

StockNews.com · Dec 26, 2024

3 Healthcare Innovators with Analyst-Endorsed Upside

Healthcare innovators are gaining momentum as they address critical challenges in biotechnology, medical devices, and pharmaceuticals. Amid this backdrop, you might consider keeping an eye on three healthcare innovators, Zoetis (ZTS), Immatics N.V. (IMTX), and Esperion Therapeutics (ESPR), which have robust upside potential. Read on….

StockNews.com · Dec 26, 2024

Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has recently underperformed the broader healthcare sector, but analysts remain optimistic about its long-term growth prospects.

Barchart · Dec 6, 2024

Zoetis's Q3 2024 Earnings: What to Expect

Zoetis will release its third-quarter earnings next month, and analysts expect a single-digit profit surge.

Barchart · Oct 18, 2024

3 Defensive Dividend Stocks to Protect Against Pre-Election Volatility

As the U.S. presidential election nears, here are three defensive dividend-paying stocks to help shield your portfolio from pre-election volatility.

Barchart · Sep 6, 2024

Is Zoetis Stock Underperforming the Dow?

Despite Zoetis’s underperformance relative to the Dow Jones Industrials Average over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

Barchart · Sep 6, 2024

3 Pet Care Stocks With Tail-Wagging Potential

The pet care industry is expected to witness immense growth owing to a surge in pet adoptions, veterinary innovations, and rising disposable income. Thus, one could scoop up shares of fundamentally solid pet-care stocks with tail-wagging potential, like Zoetis (ZTS), Chewy (CHWY), and PetIQ (PETQ). Read more….

StockNews.com · Sep 5, 2024

Should You Buy Zoetis Amid Rising Pet Care Demand?

Zoetis (ZTS) continues to showcase its solid market position and commitment to innovation across its diverse portfolio, introducing advanced products that meet the evolving needs of animal health. Given its robust fundamentals and industry leadership, let’s find out if ZTS is a solid choice for those looking to invest in…

StockNews.com · Aug 26, 2024

Zoetis Stock: Is Wall Street Bullish or Bearish?

Despite Zoetis lagging behind the broader market over the past year, analysts still remain strongly bullish on the stock’s prospects.

Barchart · Aug 21, 2024

Zoetis Earnings Preview: What to Expect

As Zoetis is all set to announce its second-quarter earnings next month, analysts project a single-digit improvement in its bottom line.

Barchart · Jul 24, 2024